CSL Behring is a global biotechnology leader that specializes in the development and delivery of innovative therapies for people with serious and rare diseases. With a strong commitment to improving the quality of life for patients, the company focuses on areas such as immunology, hematology, cardiovascular and metabolic diseases, respiratory, and transplant therapies.

Headquartered in King of Prussia, Pennsylvania, CSL Behring operates in over 30 countries and employs a diverse workforce dedicated to advancing medical science. The company is part of CSL Limited, a global biotechnology company with a rich history of over a century in the healthcare industry.

CSL Behring is committed to sustainability and has implemented various initiatives to reduce its environmental impact. The company focuses on energy efficiency, waste reduction, and sustainable sourcing. CSL Behring's sustainability efforts are guided by its Environmental, Social, and Governance (ESG) framework, which outlines its commitment to responsible business practices.

While specific details on carbon footprint calculations and sustainability certifications are not extensively available, CSL Behring continues to work towards enhancing its sustainability performance. The company actively engages with stakeholders to ensure transparency and accountability in its sustainability journey.